Trial intelligence / Profile preview

TAP Block in Elective Spine Surgery

NCT02055664Phase 4Completed

Sponsor
Centre Hospitalier Universitaire Dijon Bourgogne
Start
Jan 2014
Primary completion
Aug 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postoperative pain comparing Ropivacaine with Placebo (2 arms). Primary endpoint: Consumption of morphine at 48 hours. Started Jan 2014; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02055664.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02055664.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call